Here's What Key Metrics Tell Us About UnitedHealth (UNH) Q2 Earnings

29.07.25 15:30 Uhr

Werte in diesem Artikel
Aktien

78,00 EUR 1,50 EUR 1,96%

229,80 EUR -13,15 EUR -5,41%

Indizes

PKT PKT

44.633,0 PKT -204,6 PKT -0,46%

17.496,0 PKT -128,8 PKT -0,73%

3.135,3 PKT -13,0 PKT -0,41%

6.370,9 PKT -18,9 PKT -0,30%

UnitedHealth Group (UNH) reported $111.62 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 12.9%. EPS of $4.08 for the same period compares to $6.80 a year ago.The reported revenue represents a surprise of +0.06% over the Zacks Consensus Estimate of $111.55 billion. With the consensus EPS estimate being $4.84, the EPS surprise was -15.7%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Operating Statistics - Medical Care Ratio: 89.4% compared to the 88.6% average estimate based on nine analysts.UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based: 8.44 million versus the five-analyst average estimate of 8.48 million.UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based: 21.53 million compared to the 21.54 million average estimate based on five analysts.UnitedHealthcare Customer Profile - People Served - Total Community and Senior: 20.15 million versus the five-analyst average estimate of 20.28 million.Revenues- Investment and other income: $1.11 billion versus the nine-analyst average estimate of $1.03 billion. The reported number represents a year-over-year change of +11.1%.Revenues- Products: $13.56 billion compared to the $13.56 billion average estimate based on nine analysts. The reported number represents a change of +11.1% year over year.Revenues- Services: $9.04 billion compared to the $9.37 billion average estimate based on nine analysts. The reported number represents a change of +3.3% year over year.Revenues- Premiums: $87.91 billion versus $87.23 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +14.3% change.Revenues- Optum Insight: $4.83 billion versus $5.17 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +6.3% change.Revenues- Optum Rx: $38.46 billion versus $36.43 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +18.7% change.Revenues- Optum Health: $25.21 billion versus the six-analyst average estimate of $26.88 billion. The reported number represents a year-over-year change of -6.8%.Revenues- UnitedHealthcare- Total: $86.1 billion compared to the $84.75 billion average estimate based on six analysts. The reported number represents a change of +16.6% year over year.View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned -9.6% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UnitedHealth Inc.

Wer­bung

Analysen zu UnitedHealth Inc.

DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
09.11.2016UnitedHealth Group NeutralMizuho
31.03.2011UnitedHealth Group performOppenheimer & Co. Inc.
08.02.2011UnitedHealth Group neutralGoldman Sachs Group Inc.
15.11.2010UnitedHealth Group holdStifel, Nicolaus & Co., Inc.
20.04.2010UnitedHealth neutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
11.06.2009UnitedHealth underperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen